View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Barclays Appoints David Garner as Global Head of Securitized Products ...

NEW YORK--(BUSINESS WIRE)-- Barclays today announces the appointment of David Garner as Managing Director and Global Head of Securitized Products Bond Trading. Mr. Garner will join the bank in June and will be based in New York, reporting to Scott Eichel, Global Head of Securitized Products (“SP”). Having been identified as a future revenue driver for Barclays’ Global Markets business, David’s appointment reflects the ambitions for the SP business and further advances its goal of becoming a top 5 Securitized Products trading desk within the US; adding further momentum to a client franchise t...

Moody's assigns Aaa to Denver, CO's GO bonds, Series 2024A&B

Moody's Ratings ("Moody's") has assigned Aaa ratings to the City and County of Denver, CO's General Obligation Elevate Denver Bonds, Series 2024A in the expected par amount of $129.2 million and General Obligation Rise Denver Bonds, Series 2024B in the expected par amount of $139.7 million. Moody's ...

Apple Financial Holdings, Inc.: Update to credit analysis following ou...

Our credit view of this issuer reflects its consistent stewardship by trustees focused on long-term capital preservation, but also its comparatively weak profitability and CRE concentration.

Moose Lake ISD 97, MN: Update to credit analysis following upgrade to ...

Our credit view of this issuer reflects its increased reserves over the last three years, offset by its limited local economy.

Moody's downgrades UNFI CFR to B3

Moody's Ratings (Moody's)  downgraded the corporate family rating ("CFR") of United Natural Foods, Inc ("UNFI") to B3 from B2 and its probability of default rating ("PDR") to B3-PD from B2-PD. Concurrently, Moody's downgraded the rating of the company's senior unsecured global notes to Caa2 from Caa...

 PRESS RELEASE

MAIA Biotechnology Announces Share Purchases by Directors Cristian Lup...

CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent directors Cristian Luput and Ramiro Guerrero, J.D, LL.M. made individual purchases of 69,282 and 6,928 shares of common stock, respectively, as part of the Company’s recent private placement of common stock and warrants. Vlad Vitoc, M.D., MAIA’s Chairman and Chief Executive Officer, commented, “It’s rewarding to recognize Cristian and Ramiro, along with several additional...

 PRESS RELEASE

Holding(s) in Company

Global Ports Holding PLC (GPH) Holding(s) in Company 28-March-2024 / 18:52 GMT/BST TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BD2ZT390 Issuer Name GLOBAL PORTS HOLDING PLC UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Lullange Partners S.C.Sp City of registered office (if applicable) Howald Country of registered office (if applicable) Luxembourg 4. Details of the...

Maverick Bidco, Inc.: Update to credit analysis

Our credit view of this issuer reflects its expectation of positive cash flow generation and adequate liquidity, against its high financial leverage.

 PRESS RELEASE

MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2023 D’ARKEM...

COLOMBES, France--(BUSINESS WIRE)-- Regulatory News: Arkema (Paris:AKE) annonce la publication de son Document d’enregistrement universel 2023. Le Document d’enregistrement universel 2023 a été déposé auprès de l’Autorité des marchés financiers (AMF) le 28 mars 2024. Ce document, tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation en vigueur, est disponible sur le site internet de la société en version française à l’adresse suivante : . Ce document comprend notamment le rapport financier annuel 2023 constitué du rapport de gestion, du rapport ...

Moody's assigns Aaa to St. Johns Co., FL's non-ad valorem bonds

Moody's Ratings has assigned a Aaa to St. Johns County, FL's $8.625 million Special Obligation Refunding Revenue Bonds, Series 2024. Moody's maintains a Aaa issuer rating and Aaa non-ad valorem rating. Post-sale, the county will have approximately $150 million in governmental debt outstanding. The o...

Not-for-Profit and Public Healthcare – US: Preliminary medians – Opera...

Operating performance stabilized in 2023 as labor increases, while still elevated, eased. Stable cash mitigated the impact of expense increases, and patient volumes continued to recover.

Whidbey Island Public Hospital District, WA: Update following downgrad...

Our credit view of this issuer reflects its extremely narrow liquidity, with a growing tax base and a limited economy.

Moody's assigns Aa1 to the Shawnee County, Kansas Single Family Mortga...

Moody's Ratings (Moody's) assigns Aa1 to the proposed $15 million Shawnee County, Kansas Single Family Mortgage Revenue Bonds (Mortgage-Backed Securities Program), 2024 Series A (Non-AMT) (the "Bonds") RATINGS RATIONALE The Aa1 rating is based on the high credit quality of the security provided ...

Moody's affirms Liquid Tech's B3 CFR; outlook changed to positive

Moody's Ratings ("Moody's") changed the outlook for Liquid Tech Solutions Holdings, LLC ("Liquid Tech") to positive from stable. Moody's also affirmed the company's B3 corporate family rating, the B3-PD probability of default rating and the B3 rating on the senior secured first lien credit facilitie...

 PRESS RELEASE

Fuller, Smith & Turner PLC: Transaction in own shares

Fuller, Smith & Turner PLC (FSTA) Fuller, Smith & Turner PLC: Transaction in own shares 28-March-2024 / 18:29 GMT/BST   Fuller, Smith & Turner P.L.C. (“the Company” or “Fuller’s”)   Transaction in own shares   The Company announces that it has purchased the following number of its ‘A' ordinary shares of 40p each on the London Stock Exchange through Numis Securities Limited as part of its share buyback programme announced on 22 March 2024 (the “Programme”).   Date of Purchase 28/03/2024   Number of ‘A’ ordinary shares of 40p each ...

 PRESS RELEASE

Orange: Publication of the 2023 Universal Registration Document

Orange: Publication of the 2023 Universal Registration Document Press releaseParis, 28 March 2024 Publication of the 2023 Universal Registration Document On 28 March 2024, Orange filed its 2023 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in France in ESEF format. The document includes the following information: the 2023 Annual Financial Report; the Report of the Board of Directors on Corporate Governance; the Consolidated Non-Financial Statement,information on the next Combined Ordinary and Extraordinary Shareholders’ Meeting of 22 May...

 PRESS RELEASE

Orange: Publication du document d’enregistrement universel 2023

Orange: Publication du document d’enregistrement universel 2023 Communiqué de presseParis, le 28 mars 2024 Publication du document d’enregistrement universel 2023 Orange a déposé le 28 mars 2024 auprès de l'Autorité des Marchés Financiers (AMF) son document d’enregistrement universel 2023 au format électronique ESEF. Ce document inclut : le rapport financier annuel 2023 ;le rapport du Conseil d'administration sur le gouvernement d’entreprise ; la déclaration de performance extra-financière ;des informations sur la prochaine Assemblée générale mixte des actionnaires du 22 ma...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares Transaction in Own Shares 28 March, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 28 March 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paid Lowest price paid  Volume weighted average price paid per shareVenueCurrency28/03/2024801,700 £26.3650£26.1350£26.2544LSEGBP28/03/2024- £0.0000£0.0000£0.0000Chi-X (CXE)GBP28/03/2024- £0.0000£0.0000£0.0000BATS (BXE)GBP28/03/2024700,000 €31.08...

 PRESS RELEASE

Poxel publiera ses résultats annuels 2023 d'ici fin avril 2024

LYON, France--(BUSINESS WIRE)-- Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants pour les maladies chroniques graves à physiopathologie métabolique, dont la stéatohépatite non alcoolique (NASH) et les maladies métaboliques rares, annonce la publication, à fin avril 2024, de ses résultats annuels 2023, initialement prévue le 9 avril 2024, compte tenu de la conclusion attendue d’une transaction d’ici fin avril. La Société, ayant avancé significativement dans sa recherche de financements additionnels...

 PRESS RELEASE

Poxel to Report Its 2023 Annual Results by the End of April 2024

LYON, France--(BUSINESS WIRE)-- Regulatory News: (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, announces the publication at the end of April 2024 of its 2023 Annual Results, originally scheduled for April 9, 2024, given the expected completion of a transaction by the end of April. The Company, which has made significant progress in securing additional financing, is targeting to close, by th...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch